No CrossRef data available.
Article contents
Research Subject Injury Compensation: The Ongoing Search for Fairness, Consistency and Clarity
Published online by Cambridge University Press: 01 January 2021
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Independent Articles: Commentary
- Information
- Copyright
- Copyright © American Society of Law, Medicine and Ethics 2019
References
Chapman, C. R, Sukumaran, S., Tsegaye, G. T., Shevchenko, Y., and Caplan, A. L, “The Quest for Compensation for Research-Related Injury in the United States: A New Proposal,” Journal of Law, Medicine & Ethics 47, no. 4 (2019): 732–747.CrossRefGoogle Scholar
New Drugs and Clinical Trials Rules, 2018, Ministry of Health and Family Welfare, G.S.R. 104(E) (Feb. 1, 2018).Google Scholar
Chingarande, G. R and Moodley, K., “Disparate Compensation Policies for Research Related Injury in an Era of Multinational Trials: A Case Study of Brazil, Russia, India, China and South Africa,” BMC Medical Ethics (2018), available at <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816510/> (last visited November 13, 2019).Google Scholar
See id. (“There is need for consistency and even harmonization of such regulations at a global level. A model policy on compensation for research related injuries should borrow from the best aspects of the different policies of the BRICS countries and should be informed by the cardinal ethics principles of autonomy, justice and beneficence.”)Google Scholar